Suntory is betting on health foods and over-the-counter pharmaceuticals to hedge its fortunes and counter possible weakness in its main business lines.
So the company has started acquiring Daiichi Sankyo Healthcare, an OTC drugmaker, for ?246.5 billion ($1.5 billion), and will own the whole company in about three years.
¡°Looking at the next 10 years, we are aiming to roughly double sales through synergy and growth of existing products,¡± Toru Miyanaga, Suntory¡¯s chief strategy officer, said last week, in speaking about Daiichi Sankyo Healthcare.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.